cell-free DNA
The firm expects to replace its current screening assay with the methylation test following regulatory clearance from the country's Ministry of Food and Drug Safety.
BillionToOne Raises $55M in Series B Financing
The firm said the funding will help it pay for a recent laboratory expansion, growth of its commercial team, and new product development in the oncology space.
Tool Detects Pediatric Bone Tumors From Liquid Biopsies Based on Epigenetic Profiles
Epigenetic signatures of Ewing sarcoma affect cell-free DNA fragmentation patterns and can be used to detect cancer.
The firm continues to pursue new applications for its multiomics machine learning technology, with recent data exploring immunotherapy response prediction.
The company is positioning the blood-based test as an alternative to invasive chorionic villus sampling, the current standard in Denmark.